Entera Bio Ltd. (ENTX)
NASDAQ: ENTX · Real-Time Price · USD
1.340
-0.040 (-2.90%)
At close: Mar 18, 2026, 4:00 PM EDT
1.288
-0.052 (-3.88%)
After-hours: Mar 18, 2026, 4:52 PM EDT

Entera Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
0.120.18-0.130.570.37
Revenue Growth (YoY)
----76.53%56.44%54.66%
Cost of Revenue
0.120.17-0.10.370.3
Gross Profit
-0.01-0.030.20.07
Selling, General & Admin
5.345.14.437.255.694.85
Research & Development
5.494.54.515.856.776.38
Other Operating Expenses
--0.050.050.05-
Total Operating Expenses
10.829.598.9913.1512.5111.23
Operating Income
-10.82-9.59-8.89-13.02-12.22-11.17
Interest Income
0.060.060.030.08--
Other Non-Operating Income (Expense)
0---0.030.03
Total Non-Operating Income (Expense)
0.070.060.030.080.030.03
Pretax Income
-10.76-9.53-8.86-12.93-12.25-11.2
Provision for Income Taxes
-0.010.030.14-0.060.02
Net Income
-10.78-9.54-8.89-13.07-12.19-11.22
Net Income to Common
-10.78-9.54-8.89-13.07-12.19-11.22
Shares Outstanding (Basic)
443829292618
Shares Outstanding (Diluted)
443829292618
Shares Change (YoY)
25.06%29.79%0.69%10.23%41.90%39.62%
EPS (Basic)
-0.24-0.25-0.31-0.45-0.47-0.61
EPS (Diluted)
-0.24-0.25-0.31-0.45-0.47-0.61
Free Cash Flow
-7.09-6.82-7.33-12.55-9.08-10.61
Free Cash Flow Per Share
-0.16-0.18-0.25-0.44-0.35-0.58
Gross Margin
-4.97%-24.63%34.68%17.81%
Operating Margin
-8729.03%-5295.58%--9714.18%-2139.58%-3059.73%
Profit Margin
-8679.84%-5271.27%--9754.48%-2134.33%-3072.88%
FCF Margin
-5715.32%-3768.51%--9362.69%-1590.19%-2906.85%
EBITDA
-10.79-9.54-8.84-12.95-12.16-11.11
EBITDA Margin
-8701.61%-5270.17%--9666.42%-2130.30%-3042.47%
EBIT
-10.82-9.59-8.89-13.02-12.22-11.17
EBIT Margin
-8729.03%-5295.58%--9714.18%-2139.58%-3059.73%
Effective Tax Rate
--0.15%-0.33%-1.06%0.48%-0.18%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q